Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares rose on Thursday Nov 23 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.
Meanwhile, stocks opened flat this morning, struggling for direction in early trade ahead of congressional testimony by Federal Reserve Chairwoman Janet Yellen. Ahead of an appearance before the Joint Economic Committee, Yellen said an interest-rate hike could come “relatively soon,”
The S&P 500 SPX, +0.25% fell less than 0.1% to 2,176.85 while Dow Industrials DJIA, -0.05% fell 9 points to 18,858. The Nasdaq Composite COMP, +0.18% declined 0.1% to 5,291.48.
Maxim Group analysts reiterated its Buy rating on Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in a note to investors, making it one of the more closely watched stocks on Wall Street. The company currently has a rating of Buy on the shares. The one-year price target of $63.00 is higher than the opening price of $38.26, that has caused a number of other analysts to comment on the company recently. Looking back over the last 52 weeks, Teva Pharmaceutical Industries Ltd. stock has a high of $66.55. Stock prices sometimes get a spike to the upside when analysts reiterate coverage.
Shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) opened at $38.26 on Monday and traded in a range between, $38.01 and $38.45, and last traded at $38.33, which represents an increase of $0.26 or 0.68% from the previous closing price.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) currently has a market cap of 35.03B.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) Average Daily Trading Volume
1,980,596 shares traded hands yesterday, below the average, out of a total float 803,917,000. Look for trading volume to pick up in the coming days as swing traders often use swings in trading volume to identify substantial volume accumulation or dissemination by institutional investors.
As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to demonstrate that fund managers and other professional investors are jumping in.
Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.
These instituitional investors retain teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.
Trades for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have ranged from $37.25 – 66.55, and the stock now has a 50-day MA of $42.97 and 200-day MA of $49.87. Today’s last price is 42.40%% lower than the 52 week high of $66.55.
Earnings growth is an important factor to consider when buying stocks and investors look for companies that have increased their earnings by at least 25% for 3 consecutive years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.